Stem cell therapy has been demonstrated to induce profound healing activity in animals with various forms of arthritis. For example, the company Vet-Stem routinely utilizes stem cells in horses with various joint deformities to accelerate healing. Besides healing of damaged tissues, stem cells have the unique ability to modulate the immune system so as to shut off pathological responses while preserving ability to fight off disease. Stem cells and specifically, mesenchymal stem cells home to inflamed tissue and start producing anti-inflammatory agents. These mediators act locally and do not suppress the immune response of the patient’s whole body. Additionally, mesenchymal stem cells induce the production of T regulatory cells, a type of immune cell whose function is to protect the body against immunological self-attack.
The adult stem cells utilized to treat rheumatoid arthritis come from the patient’s own fat (autologous adipose) tissue and from donated human umbilical cord tissue (HUCT).
We collect the fat tissue sample by mini-liposuction, which is performed by a licensed plastic surgeon under general anesthesia. Mesenchymal stem cells and T regulatory cells are found within this tissue. The Medistem Panama laboratory then separates the target cells from the fat. This entire process is subjected to stringent quality control. The remaining adipose-derived stem cells are tested for quality, bacterial contamination (anaerobic and aerobic) and endotoxin before they are approved for treatment.
All umbilical cords are donated after healthy, normal births. In accordance with International Blood Bank standards, all umbilical cord-derived stem cells are rigorously screened for viruses and bacteria at Medistem Labs before they are approved for use in patients.